| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 04/30/2003 | CN1413576A Solid-state liposome containing calcareous and its preparation method |
| 04/30/2003 | CN1106853C Capsule for treating epilepsy |
| 04/30/2003 | CN1106837C Alkalinizing potassium salt controlled release preparation |
| 04/29/2003 | US6555140 Comprising spermine, spermidine, and selenium wherein the spermidine or spermine are synthetically derived. |
| 04/29/2003 | US6555137 Sucralfate-containing composition and process for the preparation thereof |
| 04/29/2003 | US6555125 Microbiocides, antiinflammatories, antihistamines and mucoadhesives |
| 04/29/2003 | US6555124 Reversibly increasing the permeability to active agents of epithelial cells; applied orally, sublingually, buccally, rectally, pulmonarily or nasally or through the mucosa of the eye. |
| 04/25/2003 | CA2409910A1 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
| 04/24/2003 | WO2003033596A1 Anti-bacterial composite particles and anti-bacterial resin composition |
| 04/24/2003 | WO2003033417A1 Titanium-group metal containing high-performance water, and its producing method and apparatus |
| 04/24/2003 | WO2003033031A1 Dosage form, device and methods of treatment |
| 04/24/2003 | WO2003033020A1 Composition and method to treat post-illness wasting phenomenon |
| 04/24/2003 | WO2003033003A1 Agent controlling the production of osteoclast formation regulator and method of screening substance capable of controlling the production of osteoclast formation regulator |
| 04/24/2003 | WO2003032973A2 Composition comprising paracetamol and a bitterness masking component |
| 04/24/2003 | WO2003032932A1 Hair repairing liquid comprising water dispersed with ultrafine particle titanium group metal by plasma underwater discharge and method and system for producing the same |
| 04/24/2003 | WO2003032928A2 Therapeutic composition and use |
| 04/24/2003 | WO2003032899A2 Methods and materials for targeting and affecting selected cells |
| 04/24/2003 | WO2003032751A1 Alkanoyl l-carnitine metal salts and dietary supplements |
| 04/24/2003 | WO2002096353A3 Polymer controlled induced viscosity fiber system and uses thereof |
| 04/24/2003 | WO2002089741A3 Compositions and methods for enhancing drug delivery |
| 04/24/2003 | WO2002043786B1 Uses for medical devices having a lubricious, nitric oxide-releasing coating for the therapy of vascular disorders |
| 04/24/2003 | WO2002024180A3 Chromium containing compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesteremia |
| 04/24/2003 | US20030078209 Porous composition, substantially insoluble in water, comprising 25% by weight oxidised cellulose and exhibiting a significant capacity to remove iron from aqueous environment; treatment of infections by iron-requiring microorganisms |
| 04/24/2003 | US20030078196 Administering cisplatin; drug delivery; reduced dosage to prevent release into systemic circulation |
| 04/24/2003 | US20030077365 Using 1,3-dibromo-5,5-dialkylhydantoin |
| 04/24/2003 | US20030077339 Plant extract for diabetic therapy |
| 04/24/2003 | US20030077336 Anti-inflammatory complex containing flaxseed oil |
| 04/24/2003 | US20030077334 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanism for normal and transformed cells |
| 04/24/2003 | US20030077333 Diarrhea therapy; gel mouth rehydration solution |
| 04/24/2003 | US20030077332 Wound healing agents; viricides |
| 04/24/2003 | US20030077330 Respiratory system disorders; remove carbon dioxide from blood |
| 04/24/2003 | US20030077243 Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use |
| 04/24/2003 | CA2463991A1 Therapeutic composition and use |
| 04/24/2003 | CA2463898A1 Methods and materials for targeting and affecting selected cells |
| 04/24/2003 | CA2463674A1 Controlled release capsules for providing both pulsed burst and controlled release of drugs to the rumen of ruminant animals over an extended time period |
| 04/24/2003 | CA2463460A1 Hair repairing liquid comprising water dispersed with ultrafine particle titanium group metal by plasma underwater discharge and method and system for producing the same |
| 04/24/2003 | CA2463425A1 Titanium-group metal containing high-performance water, and its producing method and apparatus |
| 04/24/2003 | CA2463016A1 Composition comprising paracetamol and a bitterness masking component |
| 04/23/2003 | EP1303307A2 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
| 04/23/2003 | EP1303304A2 Pharmaceutical combinations for treatment and prevention of diabetes mellitus |
| 04/23/2003 | EP1303283A2 Treatment of hyperproliferative skin disorders and diseases |
| 04/23/2003 | EP1057033B1 Treating cancer |
| 04/23/2003 | EP1057032B1 Treating cancer |
| 04/23/2003 | EP1057031B1 Treating cancer |
| 04/23/2003 | EP1057030B1 Treating cancer |
| 04/23/2003 | EP1057029B1 Treating cancer |
| 04/23/2003 | EP1057028B1 Treating cancer |
| 04/23/2003 | EP0948265B1 A method to prepare food seasoning, food ingredient and food item compositions, seasoning and use thereof |
| 04/23/2003 | EP0941085B1 Device for electrically assisted delivery of agents such as lidocaine and epinephrine |
| 04/23/2003 | EP0912442B1 Use of silica as agent for controlling the degradation of bicarbonate, resulting mixture and its application |
| 04/23/2003 | CN1411868A Bone-joining elixir and its preparation method |
| 04/23/2003 | CN1411865A Medicine for curing reduction of fracture and its production method |
| 04/23/2003 | CN1411822A 疮疡愈合散 San sore healing |
| 04/23/2003 | CN1411807A Medicine for curing hoary hair and its preparation method |
| 04/23/2003 | CN1106270C Multi-action particle for structuring biological media |
| 04/23/2003 | CN1106200C Togluo Ruanjiangao plaster and its preparing method |
| 04/23/2003 | CN1106199C Pure Chinese medicine anti-tumour medicine and its preparing process |
| 04/22/2003 | US6552089 Method of treating or preventing alopecia |
| 04/22/2003 | US6552072 Diarrhea |
| 04/22/2003 | US6551627 Medicinal herbal compounds for the prevention and treatment of diabetes |
| 04/22/2003 | US6551626 Composition containing pyrrolizidine-alkaloid-free petasites |
| 04/22/2003 | US6551492 Electrolyzed water of anode side and process for production thereof |
| 04/22/2003 | CA2263473C Silver-based antimicrobial compositions |
| 04/22/2003 | CA2239433C Compositions, containing bismuth, for the prevention and treatment of gastrointestinal disorders |
| 04/22/2003 | CA2222713C Composition comprising d-threo-methylphenidate and another drug |
| 04/17/2003 | WO2003030941A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 04/17/2003 | WO2003030928A2 Antitumor preparation |
| 04/17/2003 | WO2003030917A1 Bactericide for mrsa |
| 04/17/2003 | WO2003030914A1 Utilization of phosphatidylserine in the treatment of attention deficit syndrome (adhs) |
| 04/17/2003 | WO2003020259A3 Combinations of dmxaa and other anti-cancer agents |
| 04/17/2003 | WO2002098852A3 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins |
| 04/17/2003 | WO2002096903A3 Chemical derivatives and the use thereof as an anti-telomerase agent |
| 04/17/2003 | US20030073743 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| 04/17/2003 | US20030073712 Antiinflamamtory agents; antiischemic agents |
| 04/17/2003 | US20030073677 Synergistic mixtures; anticancer agents; 2-(2 -methyl-4-thiazolyl)ethenyl)-4,17-dioxabicyclo(14.1.0)heptadecane-5,9 -dione or 4-aza-17-oxabicyclo(14.1.0) heptadecane-5,9-dione or 1-aza-13-cyclohexadecene-2,6-dione or 1-oxa-13-cyclohexadecene-2,6-dione derivatives |
| 04/17/2003 | US20030072819 Compositions and methods for enhancing drug delivery |
| 04/17/2003 | US20030072813 Administering formulation comprising Eclipta prostrata L., Angelica dahurica, Polygonum multiforum Thumb, Astragalus complanatus, Tribulus terrestris L., Lithospermum erythrorhizon sieb et zucc Paris petiolata |
| 04/17/2003 | US20030072812 Administering at a tumor site in a mammalian subject a pharmaceutically acceptable form of at least one iron compound or complex in a suitable carrier for therapy of breast cancer |
| 04/17/2003 | US20030072810 Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals |
| 04/17/2003 | US20030072806 Antifungal formulation for therapy of fungal infection of the skin |
| 04/17/2003 | US20030072785 Mixtures for stimulating glucose up-take |
| 04/17/2003 | US20030072783 Administering nitric oxide adduct to a damaged vascular surface, wherein damaged vascular surface is interior surface of a blood vessel in which damage to endothelium or subendothelium, narrowing or stenosis of vessel has occured |
| 04/17/2003 | US20030072762 For enhancing Fc receptor-mediated antigen presentation, vaccines |
| 04/17/2003 | US20030072727 Composition and method for producing lubricating, germicide foam |
| 04/17/2003 | US20030072719 Compositions comprising a potassium salt active ingredient, including oral compositions for reducing dental nerve and dentin sensitivity comprising a non-menthol flavoring |
| 04/17/2003 | US20030070621 Apparatus and method for producing a foam bovine teat dip |
| 04/17/2003 | CA2463339A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 04/16/2003 | EP1301211A2 Multifunctional nanodevice platform |
| 04/16/2003 | EP1301077A2 Antimicrobial composition useful for the treatment of bovine mastitis |
| 04/16/2003 | EP1301076A2 Enhancing therapeutic effectiveness of nitric oxide inhalation |
| 04/16/2003 | EP1144311B1 Method for reducing the bromide content in an aqueous bromide-containing solution using hydrogen peroxide |
| 04/16/2003 | EP1112003B1 Use of a viscosity modulating polymer material for reducing tooth erosion |
| 04/16/2003 | EP1094791B1 Thixotropic formulations for filling capsules |
| 04/16/2003 | EP0961609B1 Methods for improving the health of hair and scalp |
| 04/16/2003 | EP0801554B1 Formulations and methods for reducing skin irritation |
| 04/16/2003 | EP0800382B1 Use of compositions with benzoyl peroxide, glycolic acid and zinc for the treatment of dermatological disorders |
| 04/16/2003 | EP0792154B1 Composition of cisplatin in combination with 2,2'-dithio-bis(ethanesulfonate) (dimesna) |
| 04/16/2003 | CN1411508A Oligonucleotides modulating expression of enzymes involved in synthesis of melanic pigments |
| 04/16/2003 | CN1411372A Antimicrobial compositions comprising pyroglutamic acid and optionally metal salts |
| 04/16/2003 | CN1410122A Chinese medicine preparation for treating acute condyloma |